{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:13:49Z","timestamp":1793978029665,"version":"4.8.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T00:00:00Z","timestamp":1710547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","surveyophthalmol.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.survophthal.2024.03.003","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T16:18:17Z","timestamp":1710346697000},"page":"622-631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Medication-associated orbital inflammation: A systematic review"],"prefix":"10.1016","volume":"69","author":[{"given":"Terence","family":"Ang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viraj","family":"Chaggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Y.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Selva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.survophthal.2024.03.003_bib1","article-title":"A rare case of statin-induced diplopia: An often-overlooked but reported side effect","volume":"13","author":"Abdelmasih","year":"2021","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.survophthal.2024.03.003_bib2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/BF02556671","article-title":"The acute-phase response after bisphosphonate administration","volume":"41","author":"Adami","year":"1987","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"10.1016\/j.survophthal.2024.03.003_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1365-2044.2003.03154_17.x","article-title":"Allergic reaction to hyaluronidase after a peribulbar injection","volume":"58","author":"Agrawal","year":"2003","journal-title":"Anaesthesia"},{"issue":"2","key":"10.1016\/j.survophthal.2024.03.003_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/sj.eye.6700243","article-title":"Delayed allergic reaction to hyaluronidase: a rare sequel to cataract surgery","volume":"17","author":"Ahluwalia","year":"2003","journal-title":"Eye (Lond)"},{"issue":"6","key":"10.1016\/j.survophthal.2024.03.003_bib5","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0248-8663(00)89230-9","article-title":"[Association between polymyositis and hepatitis C infection. Treatment-related difficulties]","volume":"21","author":"Alric","year":"2000","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.survophthal.2024.03.003_bib6","first-page":"1","article-title":"Orbital inflammation following COVID-19 vaccination: A case series and literature review","author":"Ang","year":"2023","journal-title":"Int Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jbspin.2010.07.012","article-title":"Anti-PL7 antisynthetase syndrome under interferon therapy","volume":"78","author":"Aouba","year":"2011","journal-title":"Jt Bone Spine"},{"issue":"2","key":"10.1016\/j.survophthal.2024.03.003_bib8","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.2500\/ar.2013.4.0051","article-title":"Sinonasal involvement in systemic vasculitides and cocaine-induced midline destructive lesions: Diagnostic controversies","volume":"4","author":"Armengot","year":"2013","journal-title":"Allergy Rhinol"},{"issue":"9","key":"10.1016\/j.survophthal.2024.03.003_bib9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5694\/mja15.00503","article-title":"Orbital myositis secondary to statin therapy","volume":"203","author":"Bahrami","year":"2015","journal-title":"Med J Aust"},{"key":"10.1016\/j.survophthal.2024.03.003_bib10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.phrs.2015.07.008","article-title":"Statin therapy and plasma coenzyme Q10 concentrations--A systematic review and meta-analysis of placebo-controlled trials.","volume":"99","author":"Banach","year":"2015","journal-title":"Pharm Res"},{"issue":"4","key":"10.1016\/j.survophthal.2024.03.003_bib11","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jaip.2020.12.047","article-title":"mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: Current evidence and suggested approach","volume":"9","author":"Banerji","year":"2021","journal-title":"J Allergy Clin Immunol Pr"},{"issue":"12","key":"10.1016\/j.survophthal.2024.03.003_bib12","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00198-005-1986-1","article-title":"Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England","volume":"16","author":"Barrera","year":"2005","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib13","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1097\/IOP.0000000000001517","article-title":"Acute unilateral ptosis and myositis following the H1N1 influenza vaccine","volume":"36","author":"Basilious","year":"2020","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.survophthal.2024.03.003_bib14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jcjo.2011.09.018","article-title":"Acute orbital inflammatory syndrome following H1N1 immunization","volume":"46","author":"Belliveau","year":"2011","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2024.03.003_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3816\/CLM.2006.n.053","article-title":"Scleritis complicating zoledronic acid infusion","volume":"7","author":"Benderson","year":"2006","journal-title":"Clin Lymphoma Myeloma"},{"issue":"3","key":"10.1016\/j.survophthal.2024.03.003_bib16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/bjo.2009.175190","article-title":"Risk factors for idiopathic orbital inflammation: a case\u2013control study","volume":"95","author":"Bijlsma","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.03.003_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ajo.2019.02.012","article-title":"Prevalence and clinical patterns of ocular complications associated with anti-PD-1\/PD-L1 anticancer immunotherapy","volume":"202","author":"Bitton","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"18","key":"10.1016\/j.survophthal.2024.03.003_bib18","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.survophthal.2024.03.003_bib19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-0032-1328337","article-title":"Bisphosphonate-associated orbital inflammatory disease and uveitis anterior--a case report and review","volume":"230","author":"B\u00f6ni","year":"2013","journal-title":"Klin Monbl Augenheilkd"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1440-0960.2009.00593.x","article-title":"Hyaluronidase allergy: a rare cause of periorbital inflammation","volume":"51","author":"Borchard","year":"2010","journal-title":"Austral J Dermatol"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib21","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1097\/IOP.0000000000002250","article-title":"A Case of Chronic Intranasal Cocaine Abuse Masquerading and Exacerbating Underlying Orbital IgG4-Related Disease","volume":"39","author":"Bruce","year":"2023","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.survophthal.2024.03.003_bib22","article-title":"A Case of Chronic Intranasal Cocaine Abuse Masquerading and Exacerbating Underlying Orbital IgG4-Related Disease","author":"Bruce","year":"2022","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.survophthal.2024.03.003_bib23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000485742","article-title":"Severe Inflammatory Ophthalmopathy in a Euthyroid Patient during Nivolumab Treatment","volume":"7","author":"Campredon","year":"2018","journal-title":"Eur Thyroid J"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib24","first-page":"136","article-title":"Orbital myositis in a rheumatoid arthritis patient during etanercept treatment","volume":"21","author":"Caramaschi","year":"2003","journal-title":"Clin Exp Rheuma"},{"key":"10.1016\/j.survophthal.2024.03.003_bib25","doi-asserted-by":"crossref","unstructured":"Carthy B, McQuaid S: Zoledronic acid React Wkly 1932 1 2022.584-584.","DOI":"10.1007\/s40278-022-27949-5"},{"issue":"4","key":"10.1016\/j.survophthal.2024.03.003_bib26","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1097\/IOP.0000000000001923","article-title":"Myositis of an Extraocular Muscle, a Possible Drug Reaction: Histopathologic and Immunopathologic Analysis","volume":"37","author":"Charles","year":"2021","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.survophthal.2024.03.003_bib27","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00198-019-04850-w","article-title":"Bisphosphonate-induced orbital inflammation: more common than once thought?","volume":"30","author":"Chehade","year":"2019","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.survophthal.2024.03.003_bib28","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/IOP.0000000000001847","article-title":"Unilateral ptosis, proptosis, and orbital myositis after shingles vaccination","volume":"37","author":"Chon","year":"2021","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"7","key":"10.1016\/j.survophthal.2024.03.003_bib29","article-title":"Tolosa-hunt syndrome presenting after COVID-19 vaccination","volume":"13","author":"Chuang","year":"2021","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.survophthal.2024.03.003_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/01658107.2013.874450","article-title":"Recurrent Optic Perineuritis after Intranasal Cocaine Abuse","volume":"38","author":"Coppens","year":"2014","journal-title":"Neuroophthalmology"},{"key":"10.1016\/j.survophthal.2024.03.003_bib31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/OTT.S57335","article-title":"Ipilimumab in the treatment of metastatic melanoma: management of adverse events","volume":"7","author":"Della Vittoria Scarpati","year":"2014","journal-title":"Onco Targets Ther"},{"issue":"11","key":"10.1016\/j.survophthal.2024.03.003_bib32","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/107999003322558782","article-title":"Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6","volume":"23","author":"Dicuonzo","year":"2003","journal-title":"J Interferon Cytokine Res"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ajo.2004.02.035","article-title":"Angioedema related to the use of hyaluronidase in cataract surgery","volume":"138","author":"Eberhart","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2024.03.003_bib34","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/01.iop.0000217573.90522.48","article-title":"Unrecognized side effect of statin treatment: unilateral blepharoptosis","volume":"22","author":"Ertas","year":"2006","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"12","key":"10.1016\/j.survophthal.2024.03.003_bib35","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ophtha.2008.08.006","article-title":"Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use","volume":"115","author":"Fraunfelder","year":"2008","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2024.03.003_bib36","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/IAE.0b013e31816576ef","article-title":"Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort","volume":"28","author":"French","year":"2008","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.survophthal.2024.03.003_bib37","article-title":"A Challenging Case of Eyelid Ptosis and Diplopia Induced by Pembrolizumab","volume":"14","author":"Garcez","year":"2022","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.survophthal.2024.03.003_bib38","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1167\/iovs.10-6081","article-title":"Glucose uptake in rat extraocular muscles: effect of insulin and contractile activity","volume":"51","author":"Garcia-Cazarin","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.survophthal.2024.03.003_bib39","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.nmd.2020.02.013","article-title":"Immune checkpoint inhibitors (ICIs)-related ocular myositis","volume":"30","author":"Garibaldi","year":"2020","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.survophthal.2024.03.003_bib40","doi-asserted-by":"crossref","first-page":"645","DOI":"10.5114\/aoms.2016.59938","article-title":"Molecular mechanisms of statin intolerance","volume":"12","author":"Gluba-Brzozka","year":"2016","journal-title":"Arch Med Sci"},{"issue":"6","key":"10.1016\/j.survophthal.2024.03.003_bib41","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archopht.1989.01070010853028","article-title":"Orbital inflammation and optic neuropathies associated with chronic sinusitis of intranasal cocaine abuse. Possible role of contiguous inflammation","volume":"107","author":"Goldberg","year":"1989","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib42","first-page":"118","article-title":"Orbital Inflammation Caused by Aminobisphosphonates","volume":"17","author":"Gonzalez Barlatay","year":"2022","journal-title":"J Ophthalmic Vis Res"},{"issue":"5","key":"10.1016\/j.survophthal.2024.03.003_bib43","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1017\/S0022215120000894","article-title":"A case series and literature review on patients with rhinological complications secondary to the use of cocaine and levamisole","volume":"134","author":"Green","year":"2020","journal-title":"J Laryngol Otol"},{"issue":"6953","key":"10.1016\/j.survophthal.2024.03.003_bib44","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/bmj.309.6953.512a","article-title":"Rhabdomyolysis after treatment with interferon alfa","volume":"309","author":"Greenfield","year":"1994","journal-title":"Bmj"},{"issue":"6","key":"10.1016\/j.survophthal.2024.03.003_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.5926","article-title":"Orbital inflammatory disease following mRNA SARS-CoV-2 vaccine","volume":"10","author":"Grunenwald","year":"2022","journal-title":"Clin Case Rep"},{"issue":"5","key":"10.1016\/j.survophthal.2024.03.003_bib46","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/ceo.13128","article-title":"Atypical case of hyaluronidase allergy with orbital compartment syndrome and visual loss","volume":"46","author":"Halliday","year":"2018","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2024.03.003_bib47","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/ceo.13659","article-title":"Zoledronic acid associated orbital inflammation","volume":"48","author":"Han","year":"2020","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2024.03.003_bib48","article-title":"Ocular Complications Following Vaccination for COVID-19: A One-Year Retrospective","volume":"10","author":"Haseeb","year":"2022","journal-title":"Vaccin (Basel)"},{"issue":"3","key":"10.1016\/j.survophthal.2024.03.003_bib49","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/01658107.2017.1368090","article-title":"Ipilimumab-induced Adenohypophysitis and Orbital Apex Syndrome: Importance of Early Diagnosis and Management","volume":"42","author":"Hassanzadeh","year":"2018","journal-title":"Neuroophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2024.03.003_bib50","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1097\/IOP.0000000000000081","article-title":"A case report of orbital inflammatory syndrome secondary to ipilimumab","volume":"31","author":"Henderson","year":"2015","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12886-019-1063-8","article-title":"Bisphosphonate-induced orbital inflammation in a patient on chronic immunosuppressive therapy","volume":"19","author":"Herrera","year":"2019","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2024.03.003_bib52","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1159\/000526225","article-title":"Orbital inflammation and dacryoadenitis after COVID-19 vaccination","volume":"13","author":"Jalink","year":"2022","journal-title":"Case Rep Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib53","doi-asserted-by":"crossref","DOI":"10.1080\/01676830.2022.2074049","article-title":"Ipilimumab-related orbitopathy: a case report","volume":"5","author":"Jebaraj","year":"2022","journal-title":"Orbit"},{"issue":"6","key":"10.1016\/j.survophthal.2024.03.003_bib54","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/01676830.2021.1939726","article-title":"Acute orbital inflammation with loss of vision: a paradoxical adverse event associated with infliximab therapy for Crohn's disease","volume":"41","author":"Jordan","year":"2022","journal-title":"Orbit"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib55","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12883-019-1416-1","article-title":"Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report","volume":"19","author":"Kamo","year":"2019","journal-title":"BMC Neurol"},{"issue":"6","key":"10.1016\/j.survophthal.2024.03.003_bib56","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.jcjo.2021.04.014","article-title":"Hypersensitivity reaction to hyaluronidase following peribulbar anesthesia: a case series","volume":"56","author":"Katahanas","year":"2021","journal-title":"Can J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2024.03.003_bib57","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.4158\/EP11081.CR","article-title":"Orbital inflammatory disease in a patient treated with zoledronate","volume":"17","author":"Kaur","year":"2011","journal-title":"Endocr Pr"},{"key":"10.1016\/j.survophthal.2024.03.003_bib58","first-page":"159","article-title":"Hyaluronidase induced orbital pseudotumor as complication of retrobulbar anesthesia","volume":"243","author":"Kempeneers","year":"1992","journal-title":"Bull Soc Belg Ophtalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2024.03.003_bib59","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0025-6196(11)60752-0","article-title":"Adverse effects of bisphosphonates: implications for osteoporosis management","volume":"84","author":"Kennel","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.survophthal.2024.03.003_bib60","doi-asserted-by":"crossref","first-page":"e792","DOI":"10.1111\/aos.14063","article-title":"Aminobisphosphonate-associated orbital and ocular inflammatory disease","volume":"97","author":"Keren","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2024.03.003_bib61","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-245359","article-title":"Zoledronic acid-induced orbital inflammation","volume":"14","author":"Khalid","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib62","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1034\/j.1600-0536.2001.440107-19.x","article-title":"Type I allergic reaction to hyaluronidase during ophthalmic surgery","volume":"44","author":"Kirby","year":"2001","journal-title":"Contact Dermat"},{"issue":"4","key":"10.1016\/j.survophthal.2024.03.003_bib63","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/sj.eye.6700673","article-title":"Orbital swelling following peribulbar and sub-Tenon's anaesthesia","volume":"18","author":"Kumar","year":"2004","journal-title":"Eye (Lond)"},{"issue":"3","key":"10.1016\/j.survophthal.2024.03.003_bib64","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/01676830.2020.1852263","article-title":"Fedratinib-induced orbital inflammation","volume":"41","author":"Lee","year":"2022","journal-title":"Orbit"},{"issue":"2","key":"10.1016\/j.survophthal.2024.03.003_bib65","first-page":"134","article-title":"A Case Series and Review of Bisphosphonate-associated Orbital Inflammation","volume":"24","author":"Lefebvre","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.survophthal.2024.03.003_bib66","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/ene.15772","article-title":"Orbital myositis induced by alendronate: a case report","volume":"30","author":"Lefeuvre","year":"2023","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.survophthal.2024.03.003_bib67","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ajem.2005.11.019","article-title":"Severe destructive sinusitis and orbital apex syndrome as a complication of intranasal cocaine abuse","volume":"24","author":"Leibovitch","year":"2006","journal-title":"Am J Emerg Med"},{"issue":"8","key":"10.1016\/j.survophthal.2024.03.003_bib68","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s00417-005-0190-5","article-title":"Allergic reaction to hyaluronidase: a rare cause of orbital inflammation after cataract surgery","volume":"244","author":"Leibovitch","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2024.03.003_bib69","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3346\/jkms.2010.25.9.1277","article-title":"Acute effects of intravenous administration of pamidronate in patients with osteoporosis","volume":"25","author":"Lim","year":"2010","journal-title":"J Korean Med Sci"},{"issue":"5","key":"10.1016\/j.survophthal.2024.03.003_bib70","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1097\/IOP.0000000000002181","article-title":"Posterior Ischemic Optic Neuropathy in the Setting of Cocaine-Induced Orbital and Sinonasal Inflammation","volume":"38","author":"Lin","year":"2022","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.survophthal.2024.03.003_bib71","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jcjo.2015.05.016","article-title":"Two cases of panuveitis with orbital inflammatory syndrome after influenza vaccination","volume":"50","author":"Manusow","year":"2015","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2024.03.003_bib72","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.4158\/EP15699.CR","article-title":"Orbital Pseudotumor in a Patient Treated With Zoledronic Acid: A Case Report and Pertinent Literature Review","volume":"2","author":"Manuylova","year":"2016","journal-title":"AACE Clin Case Rep"},{"issue":"6","key":"10.1016\/j.survophthal.2024.03.003_bib73","first-page":"837","article-title":"Ocular inflammation associated with alendronate therapy","volume":"117","author":"Mbekeani","year":"1999","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2024.03.003_bib74","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40264-013-0023-0","article-title":"Intentional Rechallenge and the Clinical Management of Drug-Related Problems","volume":"36","author":"Meyboom","year":"2013","journal-title":"Drug Saf"},{"key":"10.1016\/j.survophthal.2024.03.003_bib75","first-page":"23","article-title":"Orbital inflammation after use of zoledronic acid for metastasized prostate carcinoma","volume":"315","author":"Missotten","year":"2010","journal-title":"Bull Soc Belg Ophtalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2024.03.003_bib76","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1097\/IOP.0000000000001612","article-title":"A unique presentation of levamisole-induced antineutrophil- cytoplasmic-antibody-positive vasculitis presenting as inflammatory orbitopathy","volume":"36","author":"Muniz Castro","year":"2020","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.survophthal.2024.03.003_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01676830.2022.2134429","article-title":"Acute bilateral orbital myositis following Covid 19 vaccination","author":"Murphy","year":"2022","journal-title":"Orbit"},{"issue":"3","key":"10.1016\/j.survophthal.2024.03.003_bib78","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-248441","article-title":"Acute-onset dacryoadenitis following immunisation with mRNA COVID-19 vaccine","volume":"15","author":"Murphy","year":"2022","journal-title":"BMJ Case Rep"},{"issue":"7","key":"10.1016\/j.survophthal.2024.03.003_bib79","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/RHU.0000000000000433","article-title":"Orbital inflammation secondary to zoledronic acid, a rare presentation","volume":"22","author":"Muruganandam","year":"2016","journal-title":"J Clin Rheuma"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib80","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jcrs.2005.11.024","article-title":"Raised intraocular pressure and orbital inflammation: a rare IgE-mediated allergic reaction to sub-Tenon's hyaluronidase","volume":"32","author":"Musa","year":"2006","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"10.1016\/j.survophthal.2024.03.003_bib81","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10637-018-0659-9","article-title":"Long-term adverse event: inflammatory orbitopathy induced by pembrolizumab in a patient with metastatic melanoma","volume":"37","author":"Nardin","year":"2019","journal-title":"Invest N Drugs"},{"issue":"4","key":"10.1016\/j.survophthal.2024.03.003_bib82","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/09273970490515900","article-title":"Sinuorbital complications after intranasal cocaine abuse","volume":"12","author":"Neugebauer","year":"2004","journal-title":"Strabismus"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib83","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.1988.03720010050040","article-title":"Bilateral optic neuropathy and osteolytic sinusitis: Complications of cocaine abuse","volume":"259","author":"Newman","year":"1988","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib84","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40123-021-00415-5","article-title":"The eye of the storm: COVID-19 vaccination and the eye","volume":"11","author":"Ng","year":"2022","journal-title":"Ophthalmol Ther"},{"issue":"4","key":"10.1016\/j.survophthal.2024.03.003_bib85","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1078155207080806","article-title":"Significance and impact of bisphosphonate-induced acute phase responses","volume":"13","author":"Olson","year":"2007","journal-title":"J Oncol Pharm Pr"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib86","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/01676830.2010.535641","article-title":"Two cases of drug-induced orbital inflammatory disease","volume":"30","author":"Ortiz-Perez","year":"2011","journal-title":"Orbit"},{"issue":"7-8","key":"10.1016\/j.survophthal.2024.03.003_bib87","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1080\/09273948.2021.1906913","article-title":"Severe Cocaine-Induced Midline Destructive Lesions (CIMDL) Leading to Orbital Apex Syndrome and Peripheral Ulcerative Keratitis","volume":"30","author":"Ortiz-Seller","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.survophthal.2024.03.003_bib88","doi-asserted-by":"crossref","first-page":"96","DOI":"10.14310\/horm.2002.1226","article-title":"Bisphosphonate-associated adverse events","volume":"8","author":"Papapetrou","year":"2009","journal-title":"Horm (Athens)"},{"issue":"2","key":"10.1016\/j.survophthal.2024.03.003_bib89","first-page":"140","article-title":"Ipilimumab-induced ocular and orbital inflammation--A case series and review of the literature","volume":"24","author":"Papavasileiou","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.survophthal.2024.03.003_bib90","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/08820538.2012.760616","article-title":"Orbital inflammation secondary to a delayed hypersensitivity reaction to sub-Tenon's hyaluronidase","volume":"29","author":"Park","year":"2014","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.03.003_bib91","first-page":"1149","article-title":"Orbital myositis secondary to cytotoxic t-lymphocyte-associated protein 4 antibody \u2013 a case report","volume":"1","author":"Patel","year":"2016","journal-title":"Clin Oncol"},{"issue":"8","key":"10.1016\/j.survophthal.2024.03.003_bib92","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jcrs.2005.08.020","article-title":"Hyaluronidase allergy after peribulbar anesthesia with orbital inflammation","volume":"31","author":"Patil","year":"2005","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"10.1016\/j.survophthal.2024.03.003_bib93","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/01676830.2011.648818","article-title":"Bisphosphonate-associated orbital inflammation--a case report and review","volume":"31","author":"Peterson","year":"2012","journal-title":"Orbit"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib94","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archophthalmol.2007.17","article-title":"Orbital inflammatory disease after intravenous infusion of zoledronate for treatment of metastatic renal cell carcinoma","volume":"126","author":"Phillips","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2024.03.003_bib95","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/01676830.2015.1078380","article-title":"Bisphosphonate-induced orbital inflammation: A case series and review","volume":"34","author":"Pirbhai","year":"2015","journal-title":"Orbit"},{"issue":"6","key":"10.1016\/j.survophthal.2024.03.003_bib96","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00198-009-1048-1","article-title":"Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis","volume":"21","author":"Procianoy","year":"2010","journal-title":"Osteoporos Int"},{"issue":"7","key":"10.1016\/j.survophthal.2024.03.003_bib97","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/CJI.0000000000000178","article-title":"Severe Ocular Myositis After Ipilimumab Treatment for Melanoma: A Report of 2 Cases","volume":"40","author":"Pushkarevskaya","year":"2017","journal-title":"J Immunother"},{"issue":"4","key":"10.1016\/j.survophthal.2024.03.003_bib98","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jcrs.2003.08.024","article-title":"Hyaluronidase allergy after peribulbar anesthesia with orbital inflammation","volume":"30","author":"Quhill","year":"2004","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib99","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jcjo.2012.09.011","article-title":"Orbital inflammation after zoledronate infusion: an emerging complication","volume":"48","author":"Rahimy","year":"2013","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2024.03.003_bib100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/01676830.2017.1383465","article-title":"Hyaluronidase allergy mimicking orbital cellulitis","volume":"37","author":"Raichura","year":"2018","journal-title":"Orbit"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib101","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/IOP.0000000000000367","article-title":"Orbital myositis: a side effect of interferon alpha 2b treatment","volume":"31","author":"Rajak","year":"2015","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.survophthal.2024.03.003_bib102","first-page":"1","article-title":"Bilateral, sequential orbital inflammatory syndrome associated with ruxolitinib","author":"Rana","year":"2022","journal-title":"Orbit"},{"key":"10.1016\/j.survophthal.2024.03.003_bib103","doi-asserted-by":"crossref","DOI":"10.1097\/IOP.0000000000002161","article-title":"Orbital Inflammation Following COVID-19 Vaccination","author":"Reshef","year":"2022","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"10","key":"10.1016\/j.survophthal.2024.03.003_bib104","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/rheumatology\/38.10.984","article-title":"Pro-inflammatory effects of the aminobisphosphonate ibandronate in vitro and in vivo","volume":"38","author":"Richards","year":"1999","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.survophthal.2024.03.003_bib105","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.jaci.2021.04.002","article-title":"Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines","volume":"147","author":"Risma","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.survophthal.2024.03.003_bib106","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.vaccine.2009.12.014","article-title":"Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial","volume":"28","author":"Roman","year":"2010","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.survophthal.2024.03.003_bib107","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/rheumatology\/40.8.956","article-title":"Idiopathic orbital inflammation following intravenous pamidronate","volume":"40","author":"Ryan","year":"2001","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib108","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/IOP.0000000000001161","article-title":"Extraocular muscle enlargement and thyroid eye disease-like orbital inflammation associated with immune checkpoint inhibitor therapy in cancer patients","volume":"35","author":"Sagiv","year":"2019","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.survophthal.2024.03.003_bib109","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/00063030-200418040-00004","article-title":"Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities","volume":"18","author":"Santini","year":"2004","journal-title":"BioDrugs"},{"key":"10.1016\/j.survophthal.2024.03.003_bib110","article-title":"Orbital myositis and scleritis after anti-SARS-CoV-2 mRNA vaccines: A report of three cases","author":"Savino","year":"2022","journal-title":"Eur J Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2024.03.003_bib111","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/acr.21822","article-title":"A 55-year-old woman with orbital inflammation","volume":"64","author":"Schwab","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.survophthal.2024.03.003_bib112","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3129\/i09-110","article-title":"Orbital inflammation and optic neuropathy with zoledronic acid for metastatic prostate cancer","volume":"44","author":"Seth","year":"2009","journal-title":"Can J Ophthalmol"},{"issue":"13","key":"10.1016\/j.survophthal.2024.03.003_bib113","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMc0803366","article-title":"Zoledronic Acid Infusion and Orbital Inflammatory Disease","volume":"359","author":"Sharma","year":"2008","journal-title":"N Engl J Med"},{"issue":"3S Suppl 1","key":"10.1016\/j.survophthal.2024.03.003_bib114","article-title":"Inflammatory Orbitopathy Associated With Ipilimumab","volume":"33","author":"Sheldon","year":"2017","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib115","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/WNO.0b013e3181989adb","article-title":"Optic neuropathy caused by naso-orbital mass in chronic intranasal cocaine abuse","volume":"29","author":"Shen","year":"2009","journal-title":"J Neuroophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2024.03.003_bib116","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/01676830.2017.1337178","article-title":"Chronic orbital inflammatory disease and optic neuropathy associated with long-term intranasal cocaine abuse: 2 cases and literature review","volume":"36","author":"Siemerink","year":"2017","journal-title":"Orbit"},{"issue":"6","key":"10.1016\/j.survophthal.2024.03.003_bib117","first-page":"484","article-title":"Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S","volume":"58","author":"Skrepnek","year":"2010","journal-title":"Gen Dent"},{"issue":"9","key":"10.1016\/j.survophthal.2024.03.003_bib118","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/archopht.121.9.1335","article-title":"Orbital inflammatory disease after pamidronate treatment for metastatic prostate cancer","volume":"121","author":"Subramanian","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2024.03.003_bib119","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/WNO.0000000000001148","article-title":"Neuro-ophthalmic complications in patients treated with CTLA-4 and PD-1\/PD-L1 checkpoint blockade","volume":"41","author":"Sun","year":"2021","journal-title":"J Neuroophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2024.03.003_bib120","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1177\/1078155218785967","article-title":"Zoledronic acid-induced orbital inflammation in a patient with multiple myeloma","volume":"25","author":"Tan","year":"2019","journal-title":"J Oncol Pharm Pr"},{"issue":"8","key":"10.1016\/j.survophthal.2024.03.003_bib121","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0161-6420(84)34216-6","article-title":"A little-known phenomenon: allergic reaction to hyaluronidase","volume":"91","author":"Taylor","year":"1984","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib122","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12348-021-00275-x","article-title":"Ocular inflammatory events following COVID-19 vaccination: a multinational case series","volume":"12","author":"Testi","year":"2022","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"5","key":"10.1016\/j.survophthal.2024.03.003_bib123","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s002239900353","article-title":"An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates","volume":"61","author":"Thi\u00e9baud","year":"1997","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib124","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.ccm.0000908780.53161.d7","article-title":"762: pembrolizumab-induced myocarditis with concomitant myositis and hepatitis","volume":"51","author":"Thota","year":"2023","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib125","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/rheumatology\/36.1.120","article-title":"Polyarthropathy, orbital myositis and posterior scleritis: an unusual adverse reaction to influenza vaccine","volume":"36","author":"Thurairajan","year":"1997","journal-title":"Br J Rheumatol"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib126","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13256-021-02722-8","article-title":"Pembrolizumab-induced myasthenia gravis-like disorder, ocular myositis, and hepatitis: a case report","volume":"15","author":"Tian","year":"2021","journal-title":"J Med Case Rep"},{"issue":"4","key":"10.1016\/j.survophthal.2024.03.003_bib127","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5693\/djo.02.2017.08.002","article-title":"Diffuse ocular and orbital inflammation after zoledronate infusion-case report and review of the literature","volume":"23","author":"Umunakwe","year":"2017","journal-title":"Digit J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2024.03.003_bib128","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1097\/IOP.0b013e31829f3b46","article-title":"Nitrogen bisphosphonate-induced orbital inflammatory disease: gamma delta T cells--a report and review of 2 cases","volume":"30","author":"Vora","year":"2014","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.survophthal.2024.03.003_bib129","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/IOP.0000000000000200","article-title":"Orbital Sarcoid-Like Granulomatosis After Inhibition of Tumor Necrosis Factor-\u03b1","volume":"32","author":"Wladis","year":"2016","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.survophthal.2024.03.003_bib130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/WNO.0b013e3181c1a589","article-title":"Another case of bisphosphonate-induced orbital inflammation","volume":"30","author":"Yang","year":"2010","journal-title":"J Neuroophthalmol"},{"issue":"1323","key":"10.1016\/j.survophthal.2024.03.003_bib131","first-page":"50","article-title":"Zolendronate associated inflammatory orbital disease","volume":"123","author":"Yeo","year":"2010","journal-title":"N Z Med J"},{"issue":"12","key":"10.1016\/j.survophthal.2024.03.003_bib132","article-title":"Bisphosphonate-induced acute orbital inflammation in a patient with underlying thyroid ophthalmopathy","volume":"12","author":"Yu","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.survophthal.2024.03.003_bib133","first-page":"1","article-title":"Orbital inflammatory pseudotumor following mRNA COVID-19 vaccination","author":"Yucel Gencoglu","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.survophthal.2024.03.003_bib134","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1442-9071.2012.02834.x","article-title":"Hyaluronidase toxicity: A possible cause of postoperative periorbital inflammation","volume":"41","author":"Zamora-Alejo","year":"2013","journal-title":"Clin Exp Ophthalmol"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625724000201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625724000201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T07:15:20Z","timestamp":1731568520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625724000201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":134,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0039625724000201"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2024.03.003","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication-associated orbital inflammation: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2024.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}